# US 2018/0021339 A1 · Method for treating liver diseases of various origins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021339 A1
- Document ID: US20180021339A1
- Status: Published application
- Kind: A1
- Application number: 15/668,306
- Filed: 2017-08-03
- Published: 2018-01-25
- Earliest claimed: 2009-07-07
- Assignees: Viktor Veniaminovich Tets
- Inventors: Georgy Viktorovich Tets; Viktor Veniaminovich Tets; Konstantin Andreevich Krasnov
- Web page: https://patentgrep.com/patent/US20180021339A1

## CPC

- A61K 31/515: Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- C07D 239/66: Thiobarbituric acids
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The invention relates to medicine, in particular to gastroenterology, and lies in the field of treatment of liver diseases of various origins. For this purpose, the hepatoprotective agent that is introduced to the patient is embodied as derivatives of bis(2-thio-4,6-dioxo-1,2,3,4,5,6-hexahydropyrimidine-5-yl) arylmethanes. The method provides reduction of the manifestations of cytolysis under the influence of damaging agents and a statistically significant reduction of dysproteinemia, it accelerates restoration of detoxifying processes of the liver, increases induction of endogenic interferon alfa and, consequently, makes the protection of liver cells during hepatitides of various origins more effective.

## Claims

### Claim 1

(canceled)

### Claim 2

A method of reducing liver damage in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound selected from the group consisting of:

### Claim 3 (depends on 2)

The method of claim 2, wherein the liver damage is caused by a chemical agent.

### Claim 4 (depends on 2)

The method of claim 2, wherein the liver damage is caused by a bacterial infection.

### Claim 5 (depends on 2)

The method of claim 2, wherein the liver damage is caused by radiation.

### Claim 6 (depends on 2)

The method of claim 2, wherein the liver damage is caused by a viral infection.
